Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
levomepromazine
/
Generic mfg.
Welcome,
Profile
Billing
Logout
0 Diseases
0 Trials
0 Trials
147 News
«
1
2
3
||||||||||
Clopixol
(zuclopenthixol) /
Lundbeck
New trial:
Antipsychotics and Risk of Hyperglycemic Emergencies
(clinicaltrials.gov) - Oct 22, 2015
P=N/A
, N=725489, Completed,
Sponsor: Canadian Network for Observational Drug Effect Studies, CNODES
|
|||||||||
New P4 trial:
APIC: Antipsychotic Induced Structural and Functional Brain Changes
(clinicaltrials.gov) - May 7, 2015
P4
, N=666, Not yet recruiting,
Sponsor: RWTH Aachen University
||||||||||
New P3 trial, Adverse events:
Pharmacovigilance in Gerontopsychiatric Patients
(clinicaltrials.gov) - Mar 2, 2015
P3
, N=2000, Recruiting,
Sponsor: Hannover Medical School
||||||||||
Clopixol
(zuclopenthixol) /
Lundbeck
,
Serlect
(sertindole) /
Lundbeck, Abbott
Trial primary completion date:
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
(clinicaltrials.gov) - Dec 6, 2014
P3
, N=104, Recruiting,
Sponsor: Fundaci
Trial primary completion date: Nov 2013 --> Nov 2015
||||||||||
Lazanda
(fentanyl) /
Assertio, Kyowa Kirin
,
Epistatus
(midazolam oromucosal solution) /
Veriton Pharma
New P4 trial:
Nasal Fentanyl and Buccal Midazolam for Dying Patients
(clinicaltrials.gov) - Dec 9, 2013
P4
, N=20, Not yet recruiting,
Sponsor: Gloucestershire Hospitals NHS Foundation Trust
||||
||||||
ADX71149
/
J&J, Addex
Trial completion, Monotherapy:
Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
(clinicaltrials.gov) - Feb 28, 2013
P2
, N=100, Completed,
Sponsor: Janssen Research & Development, LLC
Trial primary completion date: Nov 2013 --> Nov 2015 Recruiting --> Completed
||
||||||||
Clopixol
(zuclopenthixol) /
Lundbeck
,
Serlect
(sertindole) /
Lundbeck, Abbott
New P3 trial:
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis
(clinicaltrials.gov) - Jan 8, 2013
P3
, N=104, Recruiting,
Sponsor: Fundaci
||||||||||
olanzapine
/
Generic mfg.
,
haloperidol
/
Generic mfg.
Trial termination:
Haloperidol vs Olanzapine for the Management of ICU Delirium
(clinicaltrials.gov) - Aug 1, 2012
P=N/A
, N=200, Terminated,
Sponsor: Richard Hall
Recruiting --> Completed Recruiting --> Terminated